Zhang Yu, Zhang Rui
Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, TX, 79409, USA.
Drug Test Anal. 2018 Jan;10(1):81-94. doi: 10.1002/dta.2290. Epub 2017 Sep 28.
Therapeutic drug monitoring (TDM) of immunosuppressive drugs (ISDs) with a narrow therapeutic index is an increasingly popular tool for minimizing drug toxicity while maximizing the prevention of graft loss and organ rejection. This review focuses on trends regarding analytical methods for the TDM of ISDs since 2011. The five most commonly prescribed immunosuppressive medications are critically reviewed: cyclosporine A, tacrolimus, sirolimus (rapamycin), everolimus, and mycophenolic acid. This review introduces the general background of TDM and ISDs and presents the recent developments in using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and immunoassays for the TDM of ISDs. Finally, a future perspective for these analytical methods is briefly discussed.
对治疗指数较窄的免疫抑制药物(ISDs)进行治疗药物监测(TDM),是一种在最大程度预防移植物丢失和器官排斥的同时,将药物毒性降至最低的日益流行的工具。本综述聚焦于自2011年以来免疫抑制药物治疗药物监测分析方法的发展趋势。对五种最常用的免疫抑制药物进行了批判性综述:环孢素A、他克莫司、西罗莫司(雷帕霉素)、依维莫司和霉酚酸。本综述介绍了治疗药物监测和免疫抑制药物的一般背景,并阐述了液相色谱-串联质谱法(LC-MS/MS)和免疫测定法在免疫抑制药物治疗药物监测中的最新进展。最后,简要讨论了这些分析方法的未来前景。